Mineralys Therapeutics, Inc. (MLYS) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$26
Day's range
$27.47

Mineralys Therapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
CATALYS PACIFIC, LLC 08/05/2026 7.90 M $213.25 M   0.00% 9.33%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 7.69 M $207.55 M   0.00% 9.08%
BLACKROCK, INC. 08/07/2026 5.89 M $158.83 M   31.36% 6.95%
SAMSARA BIOCAPITAL, LLC 08/14/2026 5.87 M $158.40 M   0.00% 6.93%
FMR LLC 08/13/2026 4.51 M $121.73 M   -7.19% 5.33%
STATE STREET CORP 08/07/2026 4.14 M $111.74 M   41.07% 4.89%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 08/14/2026 3.96 M $106.79 M   100.00% 4.67%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 2.76 M $74.38 M   12.32% 3.25%
LAURION CAPITAL MANAGEMENT LP 08/13/2026 2.51 M $67.62 M   12.28% 2.96%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 2.26 M $61.04 M   68.43% 2.67%
ORBIMED ADVISORS LLC 08/14/2026 2.11 M $56.94 M   2.80% 2.49%
CAPITAL WORLD INVESTORS 08/12/2026 2.00 M $53.90 M   401.69% 2.36%
ARMISTICE CAPITAL, LLC 08/14/2026 1.74 M $46.84 M   47.62% 2.05%
TROLUCE CAPITAL ADVISORS LLC 08/14/2026 1.73 M $46.64 M   163.93% 2.04%
FRANKLIN RESOURCES INC 08/13/2026 1.64 M $44.13 M   -8.36% 1.93%
ANDERA PARTNERS 07/22/2026 1.59 M $42.95 M   0.00% 1.88%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 1.58 M $42.75 M   21.76% 1.87%
SR ONE CAPITAL MANAGEMENT, LP 08/12/2026 1.56 M $42.20 M   0.00% 1.85%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.51 M $40.62 M   36.82% 1.78%
SPHERA FUNDS MANAGEMENT LTD. 08/14/2026 1.47 M $39.66 M   9.70% 1.73%
GOLDMAN SACHS GROUP INC 08/14/2026 1.46 M $39.36 M   85.81% 1.72%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 1.43 M $38.60 M   38.30% 1.69%
POLAR CAPITAL HOLDINGS PLC 08/14/2026 1.42 M $38.33 M   -5.32% 1.68%
MILLENNIUM MANAGEMENT LLC 08/14/2026 1.22 M $32.96 M   132.60% 1.44%
GHISALLO CAPITAL MANAGEMENT LLC 08/14/2026 1.13 M $30.35 M   100.00% 1.33%
INVESCO LTD. 08/14/2026 1.09 M $29.44 M   2,478.95% 1.29%
ALLIANCEBERNSTEIN L.P. 08/14/2026 1.07 M $28.92 M   9.38% 1.26%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 1.05 M $28.33 M   100.00% 1.24%
ARMISTICE CAPITAL, LLC 08/14/2026 1.04 M $28.06 M   100.00% 1.23%
AMERICAN CENTURY COMPANIES INC 08/12/2026 1.04 M $27.97 M   17.27% 1.22%
MORGAN STANLEY 08/13/2026 917.21 K $24.75 M   8.01% 1.08%
DAVERN CAPITAL PARTNERS, LP 08/13/2026 858.75 K $23.17 M   92.05% 1.01%
CANDRIAM S.C.A. 08/13/2026 857.04 K $23.10 M   6.88% 1.01%
CAPTION MANAGEMENT, LLC 08/14/2026 851.60 K $22.98 M   -51.37% 1.01%
NANTAHALA CAPITAL MANAGEMENT, LLC 08/19/2026 820.48 K $22.14 M   -8.38% 0.97%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2026 806.72 K $21.77 M   -75.98% 0.95%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 750.00 K $20.24 M   0.00% 0.89%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 747.66 K $20.17 M   5.80% 0.88%
TUDOR INVESTMENT CORP ET AL 08/14/2026 738.37 K $19.92 M   374.10% 0.87%
ABRDN PLC 07/31/2026 689.24 K $18.60 M   100.00% 0.81%
ALGERT GLOBAL LLC 08/13/2026 649.03 K $17.51 M   149.37% 0.77%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 648.72 K $17.50 M   47.76% 0.77%
PALE FIRE CAPITAL SE 08/13/2026 614.28 K $16.57 M   68.01% 0.73%
STEMPOINT CAPITAL LP 08/14/2026 602.69 K $16.26 M   12.99% 0.71%
NORTHERN TRUST CORP 08/13/2026 551.49 K $14.88 M   24.53% 0.65%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 521.22 K $14.06 M   17.42% 0.62%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 521.22 K $14.06 M   100.00% 0.62%
ROCK SPRINGS CAPITAL MANAGEMENT LP 08/14/2026 484.95 K $13.08 M   10.28% 0.57%
CITADEL ADVISORS LLC 09/02/2026 467.60 K $12.62 M   -22.07% 0.55%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 463.39 K $12.50 M   237.17% 0.55%

Mineralys Therapeutics Inc institutional Ownership - FAQ's

During the previous two years, 264 institutional investors and hedge funds held shares of Mineralys Therapeutics Inc. The most heavily invested institutionals were:

Catalys Pacific, LLC: 7.9 M

RA CAPITAL MANAGEMENT, L.P.: 7.69 M

BlackRock, Inc.: 5.89 M

Samsara BioCapital, LLC: 5.87 M

FMR LLC: 4.51 M

STATE STREET CORP: 4.14 M

118.26% of Mineralys Therapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 106.89 M shares in the last 24 months. This purchase volume represents approximately $2.91 B in transactions.